CA2231989A1 - Therapie pour l'insuffisance de la membrane des tissus - Google Patents

Therapie pour l'insuffisance de la membrane des tissus Download PDF

Info

Publication number
CA2231989A1
CA2231989A1 CA 2231989 CA2231989A CA2231989A1 CA 2231989 A1 CA2231989 A1 CA 2231989A1 CA 2231989 CA2231989 CA 2231989 CA 2231989 A CA2231989 A CA 2231989A CA 2231989 A1 CA2231989 A1 CA 2231989A1
Authority
CA
Canada
Prior art keywords
oligosaccharide
leakage
membrane
anionic
reduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2231989
Other languages
English (en)
Inventor
Paul B. Weisz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2231989 priority Critical patent/CA2231989A1/fr
Publication of CA2231989A1 publication Critical patent/CA2231989A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2231989 1998-03-12 1998-03-12 Therapie pour l'insuffisance de la membrane des tissus Abandoned CA2231989A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2231989 CA2231989A1 (fr) 1998-03-12 1998-03-12 Therapie pour l'insuffisance de la membrane des tissus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2231989 CA2231989A1 (fr) 1998-03-12 1998-03-12 Therapie pour l'insuffisance de la membrane des tissus

Publications (1)

Publication Number Publication Date
CA2231989A1 true CA2231989A1 (fr) 1999-09-12

Family

ID=29409441

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2231989 Abandoned CA2231989A1 (fr) 1998-03-12 1998-03-12 Therapie pour l'insuffisance de la membrane des tissus

Country Status (1)

Country Link
CA (1) CA2231989A1 (fr)

Similar Documents

Publication Publication Date Title
US5840713A (en) Therapy for tissue membrane insufficiency
US5019562A (en) Growth inhibiting agent and the use thereof
AU692389B2 (en) Cyclodextrin compounds and methods of making and use thereof
CA2261872C (fr) Procedes de traitement de l'asthme au moyen d'heparine o-desulfatee
JPH01503548A (ja) ヘパリン誘導体
JPH02502006A (ja) 抗転移活性を有する硫酸化ポリサッカライド
EP0398925B1 (fr) Agent inhibiteur de croissance et son emploi
AU694177B2 (en) Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US6127347A (en) Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
EP1453523A1 (fr) Agent ophtalmique contenant de l'heparine
JP2003089647A (ja) 関節性疾患治療剤
US20060293275A1 (en) Hgf production accelerator containing heparin-like oligosaccharide
JP3541007B2 (ja) 両親媒性ポリサッカリド誘導体
Ishikawa et al. Scleroderma-inducing glycosaminoglycan in the urine of patients with systemic scleroderma
JP2004210715A (ja) 破骨細胞形成抑制剤
JPH10503472A (ja) 筋肉処置のためのバイオポリマーの使用
CA2231989A1 (fr) Therapie pour l'insuffisance de la membrane des tissus
AU688272B2 (en) Medicameny for inhibiting neutrophil elastase and cathepsin
JP4633232B2 (ja) 成長因子誘導剤
JP4535686B2 (ja) 医薬組成物
WO1994008595A1 (fr) Utilisation d'heparine non anticoagulante dans le traitement des lesions ischemiques et consecutives a une perfusion
JP4462826B2 (ja) 骨疾患治療剤
JPH02256610A (ja) ポリアロマティック化合物を含有する医薬用組成物
JP2005068057A (ja) グリア瘢痕形成抑制剤
JPH02124902A (ja) 血液凝固抑制剤

Legal Events

Date Code Title Description
FZDE Dead